Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: Results of the Japan Clinical Oncology Group Study 9104
Takada M et al. (2002) Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: Results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 20: 3054-3060
Pilot study of concurrent etoposide and cisplatin plus accelerated hyperfractionated thoracic radiotherapy followed by irinotecan and cisplatin for limited-stage small cell lung cancer: Japan Clinical Oncology Group 9903
Kubota K et al. (2005) Pilot study of concurrent etoposide and cisplatin plus accelerated hyperfractionated thoracic radiotherapy followed by irinotecan and cisplatin for limited-stage small cell lung cancer: Japan Clinical Oncology Group 9903. Clin Cancer Res 11: 5534-5538
CNS metastases in small cell bronchogenic carcinoma: Increasing frequency and changing pattern with lengthening survival
Nugent JL et al. (1979) CNS metastases in small cell bronchogenic carcinoma: Increasing frequency and changing pattern with lengthening survival. Cancer 44: 1885-1893
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission
Prophylactic Cranial Irradiation Overview Collaborative Group
Auperin A et al. (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 341: 476-484
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission
Arriagada R et al. (1995) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst 87: 183-190
A retrospective analysis of patients receiving surgery after chemotherapy for small cell lung cancer
Yamada K et al. (1991) A retrospective analysis of patients receiving surgery after chemotherapy for small cell lung cancer. Jpn J Clin Oncol 21: 39-45
Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with complately resected stage I-IIIa small cell lung cancer: The Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101)
Tsuchiya R et al. (2005) Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with complately resected stage I-IIIa small cell lung cancer: The Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). J Thorac Cardiovasc Surg 129: 977-983